U.S. federal trademark · Serial No. 90881874 · Reg. No. 7009210
Clinical and laboratory research and testing, research testing of materials, namely, the use of genetically-engineered pigs, into which an adenoviral vector encoding Cre recombinase is induced, resulting in the formation of tumors in the target organ; research testing protocols conducting testing on tumors via drug or medical device, with subsequent collection of data, tissue samples, and/or images to assess the development and performance of cancer treatments, diagnostics, devices, and drugs
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.